Sutro Biopharma Inc (STRO) gains 1.22% for July 15

Equities Staff  |

Sutro Biopharma Inc (NASDAQ: STRO) shares gained 1.22%, or $0.21 per share, to close Thursday at $17.42. After opening the day at $17.14, shares of Sutro fluctuated between $17.85 and $16.87. 324,909 shares traded hands a decrease from their 30 day average of 478,556. Thursday's activity brought Sutro’s market cap to $803,287,624.

Sutro is headquartered in South San Francisco, California..

About Sutro Biopharma Inc

Sutro Biopharma, Inc., located in South San Francisco, is a clinical-stage drug discovery, development and manufacturing company. Using precise protein engineering and rational design, Sutro is advancing next-generation oncology therapeutics.

Visit Sutro Biopharma Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Sutro Biopharma Inc and to follow the company’s latest updates, you can visit the company’s profile page here: Sutro Biopharma Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:

Market Movers

Sponsored Financial Content